-
1761
-
1762
Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence
Published 2021-01-01Get full text
Article -
1763
-
1764
Implementation of a sexual health clinic in an oncology setting: patient and provider perspectives
Published 2025-01-01Get full text
Article -
1765
-
1766
-
1767
-
1768
-
1769
-
1770
Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
Published 2016-01-01Get full text
Article -
1771
Astragaloside IV attenuates cadmium induced nephrotoxicity in rats by activating Nrf2
Published 2025-01-01Get full text
Article -
1772
Versatility of the Anterolateral Thigh Flap for Abdominal Wall Reconstruction
Published 2025-01-01Get full text
Article -
1773
Epidemiology of urinary tract infections in the Middle East and North Africa, 1990–2021
Published 2025-02-01Get full text
Article -
1774
Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer
Published 2025-02-01Get full text
Article -
1775
-
1776
J Point and ST Elevation Resembling Brugada: A Marker of Mortality in Methanol Toxicity
Published 2021-01-01Get full text
Article -
1777
-
1778
Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
Published 2015-01-01“…Data were collected by 48 physicians from oncology (patient N=344) and 8 physicians from urology (patient N=50) practices. Inclusion criteria were: CRPC diagnosed between 2004 and 2010; received docetaxel; discontinued docetaxel due to rising prostate-specific antigen (PSA), progression of bone lesions, or progression of nodal or visceral metastases. …”
Get full text
Article -
1779
-
1780